The latest findings could lead to more targeted ways to increase insulin-stimulated glucose uptake by muscle and exercise tolerance.
Horst succeeds Bryan Harris, MD, MPH, MMHC, current executive vice chair for Clinical Affairs, who has been named interim chair of Medicine.
During his 20-year career at VUMC, he developed the Vanderbilt Small Bowel Center and was a leader in endoscopic innovation.
Understanding factors that contribute to the development of colorectal cancer could point to new targets for treating the disease at earlier stages, when survival rates are highest.
He will serve successive one-year terms as AGA vice president, president-elect, president in 2027-2028, and then past president.
The center was created earlier this year to save the lives of patients waiting for a transplant and improve outcomes for patients after they receive a transplant.